Researchers investigated the effects of leucine-rich repeat-containing 8 A (LRRC8A) on oxaliplatin resistance in colon cancer cells. The cell viability was measured after oxaliplatin treatment with cell counting kit-8 assay.
[Heliyon]
Home Newsletters Intestinal Cell News LRRC8A Promotes the Initial Development of Oxaliplatin Resistance in Colon Cancer Cells
